Location History:
- Kashiwa, JP (1980)
- Gyoda, JP (1990)
Company Filing History:
Years Active: 1980-1990
Title: The Innovations of Takatoshi Nagate
Introduction
Takatoshi Nagate is a notable inventor based in Gyoda, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antibacterial properties. With a total of two patents to his name, Nagate's work has had a meaningful impact on medical science.
Latest Patents
Nagate's latest patents include a process for preparing 14-hydroxy-6-O-methyl-erythromycin A. This process involves cultivating Mucor circinelloides f. griseo-cyanus IFO 4563 in a medium containing 6-O-methylerythromycin A as a substrate. The resulting compound and its salt exhibit antibacterial activity. Another significant patent focuses on novel amylase inhibitors. These inhibitors, known as TAI-A and TAI-B, are obtained by inoculating a seed of the strain of Streptomyces calvus TM-521 into an aqueous nutrient medium. The cultivation process, which can be done with shaking or by submerged culture method with aeration, leads to the separation of these amylase inhibitors from the cultured broth.
Career Highlights
Nagate is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to developing effective medical solutions that address various health challenges.
Collaborations
Nagate has collaborated with esteemed colleagues such as Sadafumi Omura and Joji Sasaki. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.
Conclusion
Takatoshi Nagate's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to advancing medical science. His work continues to influence the development of effective treatments, showcasing the importance of innovation in healthcare.